Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Lymphoblastic, Acute, L2”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Study completedNCT01310010
What this trial is testing

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 30
Testing effectiveness (Phase 2)UnknownNCT01005758
What this trial is testing

Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Ohio State University Comprehensive Cancer Center 180
Large-scale testing (Phase 3)Study completedNCT00002812
What this trial is testing

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 2,078
Early research (Phase 1)Looking for participantsNCT05043571
What this trial is testing

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LeukemiaLymphoblastic Leukemia, Acute Adult+4 more
National University Hospital, Singapore 20
Testing effectiveness (Phase 2)Looking for participantsNCT05648019
What this trial is testing

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Who this might be right for
Lymphoblastic LeukemiaLymphoblastic Leukemia in ChildrenLymphoblastic Leukemia, Acute Adult+3 more
KK Women's and Children's Hospital 40
Not applicableUnknownNCT01185886
What this trial is testing

Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
European Organisation for Research and Treatment of Cancer - EORTC 1,200
Testing effectiveness (Phase 2)Study completedNCT00003700
What this trial is testing

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 163
Testing effectiveness (Phase 2)Study completedNCT00458848
What this trial is testing

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 470
Testing effectiveness (Phase 2)Study completedNCT00022126
What this trial is testing

Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 6
Early research (Phase 1)UnknownNCT05038696
What this trial is testing

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LeukemiaLymphoblastic Leukemia, Acute Adult+3 more
National University Hospital, Singapore 40
Testing effectiveness (Phase 2)Study completedNCT00109837
What this trial is testing

S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 79
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT00002665
What this trial is testing

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

Who this might be right for
LeukemiaNeutropeniaThrombocytopenia
SWOG Cancer Research Network 50
Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Large-scale testing (Phase 3)Looking for participantsNCT06051409
What this trial is testing

Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Who this might be right for
Ph+ ALLLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc. 350
Early research (Phase 1)Study completedNCT00005593
What this trial is testing

Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Case Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00337168
What this trial is testing

S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 36
Early research (Phase 1)Study completedNCT00002588
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

Who this might be right for
Leukemia
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00281879
What this trial is testing

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 200
Testing effectiveness (Phase 2)Looking for participantsNCT07387926
What this trial is testing

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 50
Next Page